Sculpting ion channel functional expression with engineered ubiquitin ligases by Kanner, Scott A. et al.
Figures and figure supplements
Sculpting ion channel functional expression with engineered ubiquitin ligases
Scott A Kanner et al



























Figure 1. Role of ubiquitin in the lifecycle of membrane proteins. (A) Dynamic trafficking of membrane proteins
among subcellular compartments. Degradation can take place from the ER via the proteasome, or through
downstream endocytic compartments via the lysosome. Ubiquitin (purple) is a molecular signal important for
mediating multiple steps in membrane protein trafficking, function, and degradation. Forward trafficking (green)
and reverse trafficking (red) processes are represented. (B) Enzymatic cascade of ubiquitination, including the ATP-
dependent activation of ubiquitin (E1), ubiquitin conjugation (E2), and ultimate ubiquitin transfer to target
substrate (E3). CHIP is an E3 ligase, recognizing Hsp70-bound substrates via the TPR binding domain and
catalyzing their ubiquitination via the U-box domain (hexagon). (C) Schematic for engineering an E3 ubiquitin
ligase and potential outcomes on an ion channel substrate. The substrate-binding TPR domain of CHIP is replaced
with GFP-binder, vhh4 nanobody, creating nanoCHIP which has novel selectivity towards YFP-tagged Q1 subunits.
The bungarotoxin binding site (BBS) epitope (S1–S2) allows for selective labeling of surface Q1 subunits, YFP
signal represents total Q1 expression. This experimental paradigm enables robust analysis of Q1 stability,
trafficking, and function.
DOI: https://doi.org/10.7554/eLife.29744.003
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Figure 2. nanoCHIP selectively abolishes Q1 surface expression. (A–C) Cartoons of experimental strategies. BBS-Q1-YFP was co-transfected with either
nanobody alone (A) or with nanoCHIP (B). Untagged BBS-Q1 co-expressed with nanoCHIP was used as a control to test for specificity of the approach
(C). (D) Flow cytometry analyses of total Q1 expression (YFP fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-
YFP + nanoCHIP (right).~50,000 cells are represented in dot plots here and throughout. Vertical and horizontal lines represent thresholds for CFP and
YFP-positive cells, respectively, based on analyses of single color controls. Represented are CFP-positive cells with YFP signal above (green dots) or
below threshold (blue dots); YFP-positive cells with CFP signal below threshold (gray dots); and untransfected cells (black dots). (E) Cumulative
distribution histograms of YFP fluorescence for BBS-Q1-YFP co-expressed with either nanobody (black line) or nanoCHIP (red line). Plot generated from
population of YFP- and CFP-positive cells. Dotted line is threshold value for YFP signal. (F) Flow cytometry analyses of surface Q1 channels (Alexa647
fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + nanoCHIP (right). Representative confocal images are inset.
(G) Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either nanobody (black line) or nanoCHIP (red line).
Plot generated from population of CFP-positive cells. Dotted line is threshold value for Alexa647 signal. (H,I) Flow cytometry analyses of surface Q1
channels in cells expressing BBS-Q1 with either nanobody alone or with nanoCHIP. Same format as (F,G).
DOI: https://doi.org/10.7554/eLife.29744.004
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Figure 2—figure supplement 1. Titration of nanoCHIP expression. (A,C,E) Flow cytometry analyses of surface Q1 channels (Alexa647 fluorescence) in
cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + nanoCHIP (right), using 1:1 (A), 1:3 (C), and 1:5 (E) transfection ratios of BBS-
Q1-YFP:nanoCHIP plasmids. (B,D,F) Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either nanobody
(black line) or nanoCHIP (red line).
DOI: https://doi.org/10.7554/eLife.29744.005
Kanner et al. eLife 2017;6:e29744. DOI: https://doi.org/10.7554/eLife.29744 4 of 21































































Figure 2—figure supplement 2. Catalytically inactive nanoCHIP* has no effect on Q1 surface expression. (A) Flow cytometry analyses of total Q1
expression (YFP fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control), BBS-Q1-YFP + nanoCHIP (center), and BBS-Q1-
YFP + nanoCHIP* [D128–229] (right). (B) Cumulative distribution histograms of YFP fluorescence for BBS-Q1-YFP co-expressed with either nanobody
alone (black line), nanoCHIP (red line), and nanoCHIP* [D128–229] (blue line). (C) Flow cytometry analyses of surface Q1 channels (Alexa647 fluorescence)
in cells expressing BBS-Q1-YFP + nanobody (left, control), BBS-Q1-YFP + nanoCHIP (center), and BBS-Q1-YFP + nanoCHIP* [D128–229] (right). (D)
Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either nanobody alone (black line), nanoCHIP (red line),
and nanoCHIP* [D128–229] (blue line).
DOI: https://doi.org/10.7554/eLife.29744.006
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Figure 2—figure supplement 3. Screening the effects of different engineered E3 ligases. (A) Flow cytometry analyses of total Q1 expression (YFP
fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + nanoCHIP, nanoNSlmb (termed deGradFP), or nanoMDM2.
(B) Cumulative distribution histograms of YFP fluorescence for BBS-Q1-YFP co-expressed with either nanobody (black line) or nanoCHIP (red line),
nanoNSlmb (blue line), or nanoMDM2 (orange line). (C) Flow cytometry analyses of surface Q1 channels (Alexa647 fluorescence) in cells expressing BBS-
Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + nanoCHIP, nanoNSlmb, or nanoMDM2. (D) Cumulative distribution histograms of Alexa647
fluorescence for BBS-Q1-YFP co-expressed with either nanobody (black line) or nanoCHIP (red line), nanoNSlmb (blue line), or nanoMDM2 (orange
line).
DOI: https://doi.org/10.7554/eLife.29744.007
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Figure 2—figure supplement 4. Engineered nanoNEDD4-2 decreases both Q1 surface density and total protein expression. (A) Flow cytometry
analyses of total Q1 expression (YFP fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control), BBS-Q1-YFP + nanoNEDD4-2 (center),
and BBS-Q1-YFP + nanoNEDD4-2* [C942S] (right). (B) Cumulative distribution histograms of YFP fluorescence for BBS-Q1-YFP co-expressed with either
nanobody alone (black line), nanoNEDD4-2 (red line), and nanoNEDD4-2* [C942S] (blue line). (C) Flow cytometry analyses of surface Q1 channels
(Alexa647 fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control), BBS-Q1-YFP + nanoNEDD4-2 (center), and BBS-Q1-
YFP + nanoNEDD4-2* [C942S] (right). (D) Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either
nanobody alone (black line), nanoNEDD4-2 (red line), and nanoNEDD4-2* [C942S] (blue line).
DOI: https://doi.org/10.7554/eLife.29744.008
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Figure 3. nanoCHIP increases Q1 ubiquitination. (A) Left, Q1 pulldowns probed with anti-Q1 antibody from HEK293 cells expressing Q1-
YFP ± NEDD4-2, and untransfected controls (UT). Right, densitometric analyses of anti-Q1 Western blot bands. (B) Left, Anti-ubiquitin labeling of the
stripped Western blot from (A). Right, densitometric analyses of anti-ubiquitin Western blot bands. (C) Relative Q1 ubiquitination computed by ratio of
anti-ubiquitin to anti-Q1 signal intensity. (D–F) Anti-Q1 and anti-ubiquitin Western blot signals from HEK293 cells expressing Q1-YFP with either
nanobody alone or nanoCHIP. Same format as (A–C). **p<0.01, Student’s t test.
DOI: https://doi.org/10.7554/eLife.29744.009
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Figure 3—figure supplement 1. Full-length NEDD4-2 diminishes both Q1 surface density and total protein expression. (A) Flow cytometry analyses of
total Q1 expression (YFP fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + NEDD4-2 (right). (B) Cumulative
distribution histograms of YFP fluorescence for BBS-Q1-YFP co-expressed with either nanobody alone (black line) or NEDD4-2 (red line). (C) Flow
cytometry analyses of surface Q1 channels (Alexa647 fluorescence) in cells expressing BBS-Q1-YFP + nanobody (left, control) or BBS-Q1-YFP + NEDD4-2
(right). (D) Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either nanobody alone (black line) or NEDD4-
2 (red line).
DOI: https://doi.org/10.7554/eLife.29744.010
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Figure 4. nanoCHIP regulation of Q1/KCNE1 complex surface density. (A) Cartoon of BBS-Q1-YFP + KCNE1. (A) Flow cytometry analyses of surface
Q1 channels (Alexa647 fluorescence) in HEK293 cells expressing BBS-Q1-YFP + KCNE1 with either nanobody (left, control) or nanoCHIP (right). (C)
Cumulative distribution histograms of Alexa647 fluorescence for BBS-Q1-YFP co-expressed with either nanobody (black line) or nanoCHIP (red line). (D–
F) Schematic, flow cytometry analyses, and cumulative distribution histograms from cells expressing BBS-Q1 + KCNE1 with either nanobody alone or
nanoCHIP. Same format as (A–C). (G–I) Schematic, flow cytometry analyses, and cumulative distribution histograms from cells expressing BBS-
Q1 + KCNE1-YFP with either nanobody alone or nanoCHIP. Same format as (A–C). (J) Left, Q1 pulldowns probed with anti-Q1 antibody from HEK293
cells expressing Q1 + KCNE1-YFP with nanobody alone, nanoCHIP, or NEDD4-2. UT, untransfected cells. Right, densitometric analyses of anti-Q1
Figure 4 continued on next page
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Figure 4 continued
Western blot bands for the different conditions. (K) Left, Anti-ubiquitin labeling of the stripped Western blot from (J). Right, densitometric analyses of
anti-ubiquitin Western blot bands.
DOI: https://doi.org/10.7554/eLife.29744.011
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Figure 4—figure supplement 1. nanoCHIP has no effect on Q1/E1 total protein expression. (A) Flow cytometry analyses of total Q1 expression (YFP
fluorescence) in cells expressing BBS-Q1-YFP + KCNE1 with either nanobody (left, control) or nanoCHIP (right). (B) Cumulative distribution histograms
of YFP fluorescence for BBS-Q1-YFP + KCNE1 co-expressed with either nanobody (black line) or nanoCHIP (red line). (C,D) Flow cytometry analyses,
and cumulative distribution histograms from cells expressing BBS-Q1 + KCNE1-YFP with either nanobody alone or nanoCHIP. Same format as (A,B).
DOI: https://doi.org/10.7554/eLife.29744.012
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Figure 5. Functional knockdown of reconstituted Iks by nanoCHIP. (A) Schematic, Q1-YFP + KCNE1. (B) Exemplar family of IKs reconsitituted in CHO
cells expressing Q1-YFP + KCNE1 with either nanobody alone (left) or nanoCHIP (right). (C) Population I-V curves for nano (&, n = 5) and nanoCHIP (&,
n = 5). (D–F) Schematic, exemplar currents and population I-V curves for CHO cells expressing Q1 + KCNE1 with either nanobody (~, n = 14) or
nanoCHIP (~, n = 12). Same format as (A–C). (G–I) Schematic, exemplar currents and population I-V curves for CHO cells expressing Q1 + KCNE1-YFP
with either nanobody (., n = 13) or nanoCHIP (., n = 8). Same format as (A–C). **p<0.01, Student’s t test.
DOI: https://doi.org/10.7554/eLife.29744.013
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Figure 5—figure supplement 1. Functional knockdown of Iks reconstituted in HEK293 cells by nanoCHIP.
Population I-V curves from HEK293 cells expressing Q1-YFP + KCNE1 with either nanobody alone (&, n = 9) or
nanoCHIP (&, n = 5).
DOI: https://doi.org/10.7554/eLife.29744.014
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Figure 6. A small-molecule-inducible system for temporal control of Q1 surface expression. (A) Cartoon showing
FKBP/FRB heterodimerization strategy for rapamycin-induced recruitment of engineered E3 ligase (iN-CHIP) to
Figure 6 continued on next page
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Figure 6 continued
Q1-YFP. (B) Representative flow cytometry dot plots (left) and histograms (right) showing evolution of surface Q1
channels in cells expressing BBS-Q1-YFP + FRB-CHIP + FKBP-nano at varying time intervals after rapamycin
induction. (C) Plot of normalized mean Q1 surface density (Alexa647 fluorescence) as a function of time after
rapamycin induction (D, n = 1355–1523 cells; N = 3). Smooth curve is an exponential decay function fit to the data:
y ¼ Ae
 t
t þ y0, with A = 0.87 ± 0.03, y0 = 0.10 ± 0.02, t = 208.8 ± 17.4 mins.
DOI: https://doi.org/10.7554/eLife.29744.015
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Figure 6—figure supplement 1. . iN-CHIP does not modulate surface expression of untagged BBS-Q1.
Cumulative distribution histograms of Alexa647 fluorescence in cells expressing BBS-Q1 + FKBP-nano + FRB-CHIP
after addition of DMSO (black) or rapamycin (red) for 20 hr.
DOI: https://doi.org/10.7554/eLife.29744.016
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Figure 7. iN-CHIP selectively impairs Q1-YFP forward trafficking. (A) Schematic showing optical pulse-chase assay for measuring BBS-Q1-YFP forward
trafficking. Cells expressing BBS-Q1-YFP + FRB-CHIP + FKBP-nano were induced with rapamycin and initial surface channels blocked by incubation with
untagged a-bungarotoxin (BTX) at 4˚C. Cells were washed and placed back at 37˚C for varying time intervals (5, 10, 20, 40, 60 min) to resume delivery
of new channels to the surface membrane. Newly delivered channels were labeled with Alexa Fluor 647 conjugated BTX (BTX647) at 4˚C and analyzed
using flow cytometry. (B) Time evolution of BBS-Q1-YFP delivery to the surface without (., n = 2878–3905 cells; N = 2) or with (&, n = 2990–3469 cells;
N = 2) rapamycin induction. Smooth curves are fits of an exponential growth function to the data: y ¼ Ae
t
t þ y0. For .; A =  45.1 ± 3.8, y0 = 44.1 ± 3.0,
t = 13.4 ± 3.0 mins. For &; A =  180.5 ± 7.0, y0 = 179.9 ± 7.7, t = 36.1 ± 3.2 mins. (C) Schematic showing optical assay for measuring BBS-Q1-YFP
internalization. Cells expressing BBS-Q1-YFP + FRB-CHIP + FKBP-nano were induced with rapamycin and initial surface channels labeled with biotin-
conjugated BTX (BTX-biotin) at 4˚C. Cells were washed and incubated at 37˚C for varying time intervals (5, 10, 20, 40, 60 min) to allow for internalization
of surface channels. The remaining surface channels were labeled with Alexa Fluor 647-conjugated streptavidin (SA-647) at 4˚C. (D) Time evolution of
loss of surface BBS-Q1-YFP channels without (., n = 3430–4919 cells; N = 2) or with (&, n = 3336–4744 cells; N = 2) rapamycin induction. Smooth curves
are fits of an exponential decay function to the data: y ¼ Ae
 t
t þ y0. For .; A = 0.93 ± 0.03, y0 = 0.06 ± 0.02, t = 12.8 ± 1.1 mins. For &; A = 0.98 ± 0.03,
y0 = 0.03 ± 0.03, t = 15.3 ± 1.3 mins.
DOI: https://doi.org/10.7554/eLife.29744.017
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Figure 8. nanoCHIP eliminates Q1 surface expression in cardiomyocytes. (A) Exemplar adult rat cardiomyocyte
expressing BBS-Q1-YFP + nanobody-P2a-CFP. Fluorescence shows surface Q1 (QD655 signal, left), total Q1 (YFP
signal, middle) and marker for nanobody expression (CFP signal, right). (B) Exemplar cardiomyocyte co-expressing
BBS-Q1-YFP and nanoCHIP. Same format as (A). (C) Comparison of surface Q1 channels in cardiomyocytes co-
expressing either nanobody (., n = 24) or nanoCHIP (&, n = 20). ***p<0.0001, Student’s unpaired t test. (D)
Comparison of total Q1 channels in cardiomyocytes co-expressing either nanobody (., n = 24) or nanoCHIP (&,
n = 20).
DOI: https://doi.org/10.7554/eLife.29744.018
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* * * * *
*
α1C
Figure 9. Functional knockdown of recombinant Cav1.2 channels by nanoCHIP. (A) Schematic of CaV1.2 pore-forming a1C and auxiliary b subunit
complex. An extracellular BBS epitope tag placed on the domain II S5-S6 loop permits detection of surface channels using Alex Fluor647-conjugated
Figure 9 continued on next page
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Figure 9 continued
bungarotoxin. A YFP tag on a1C C-terminus reports on the total expression and serves as a docking site for nanoCHIP. (B) Flow cytometry analyses of
total a1C expression (YFP fluorescence) in cells expressing BBS-a1C-YFP + b2a together with either nanobody (left, control) or nanoCHIP (right). (C)
Cumulative distribution histograms of YFP fluorescence for BBS-a1C-YFP + b2a co-expressed with either nanobody (black line) or nanoCHIP (red line).
(D) Flow cytometry analyses of surface a1C (Alexa647 fluorescence) in cells expressing BBS-a1C-YFP + b2a + nanobody (left, control) or BBS-a1C-YFP +
b2a + nanoCHIP (right). (E) Cumulative distribution histograms of Alexa647 fluorescence for BBS-a1C-YFP + b2a co-expressed with either nanobody (black
line) or nanoCHIP (red line). (F) Exemplar Ba2+ currents from CaV1.2 channels reconstituted in HEK293 cells expressing a1C-YFP + b2a with either
nanobody alone (left) or nanoCHIP (right). (G) Population I-V curves for a1C-YFP + b2a reconstituted with either nano (&, n = 10) or nanoCHIP (&, n = 14).
*p<0.05, Student’s unpaired t test.
DOI: https://doi.org/10.7554/eLife.29744.019
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